|
| Workforce | Percentage (%) |
Breast | Non-specific invasive carcinoma | 99 | 77.90 |
Ductal adenocarcinoma | 17 | 13.40 | |
Mucinous adenocarcinoma | 6 | 4.70 | |
Papillary invasive adenocarcinoma | 2 | 1.60 | |
Papillary carcinoma | 2 | 1.60 | |
Medullary carcinoma | 1 | 0.80 | |
Total | 127 | 100.00 | |
Uterine cervix | Invasive squamous cell carcinoma | 43 | 65.10 |
Squamous cell carcinoma in situ | 18 | 27.30 | |
Invasive adenocarcinoma | 4 | 6.10 | |
Other | 1 | 1.50 | |
Total | 66 | 100.00 | |
Uterine body | Adenocarcinomas | 11 | 61.10 |
Endometrioid carcinoma | 5 | 27.80 | |
Other | 2 | 11.10 | |
Total | 18 | 100.00 | |
Ovaries | Epithelial tumours | 7 | 58.30 |
Undifferentiated carcinoma | 3 | 25.00 | |
Other | 2 | 16.70 | |
Total | 12 | 100.00 | |
Vulva | Invasive squamous cell carcinoma | 4 | 100.00 |
Vagina | Invasive squamous cell carcinoma | 4 | 100.00 |